Skoupa, Jana <br/><br/>
Indacaterol/Glycopyrronium versus Salmeterol/Fluticasone in Patients with COPD-A Cost-Effectiveness Analysis in the Czech Republic.  [electronic resource] 

 -  Value in health regional issues  Sep 2018 
 - 112-118 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2212-1102 
<br/><br/><label>Standard No.: </label>10.1016/j.vhri.2018.09.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Bronchodilator Agents--administration & dosage<br/>Cost-Benefit Analysis<br/>Czech Republic<br/>Female<br/>Fluticasone-Salmeterol Drug Combination--administration & dosage<br/>Glycopyrrolate--administration & dosage<br/>Humans<br/>Indans--administration & dosage<br/>Male<br/>Muscarinic Antagonists--administration & dosage<br/>Pulmonary Disease, Chronic Obstructive--drug therapy<br/>Quality-Adjusted Life Years<br/>Quinolones--administration & dosage